BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gregorio GV, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, Garson J, Bogdanos DP, Vegnente A, Mieli-Vergani G, Vergani D. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol. 2003;133:404-413. [PMID: 12930368 DOI: 10.1046/j.1365-2249.2003.02229.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Agha S, El-Mashad N, El-Malky M, El-Shony H, El-Sherif MZ, El-Hasan MA, Tanaka Y, Mizokami M. Prevalence of low positive anti-HCV antibodies in blood donors: Schistosoma mansoni co-infection and possible role of autoantibodies. Microbiol Immunol 2006;50:447-52. [PMID: 16785716 DOI: 10.1111/j.1348-0421.2006.tb03813.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
2 Bogdanos D, Pusl T, Rust C, Vergani D, Beuers U. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol. 2008;49:466-473. [PMID: 18644655 DOI: 10.1016/j.jhep.2008.05.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
3 Christen U, Hintermann E. Pathogens and autoimmune hepatitis. Clin Exp Immunol. 2019;195:35-51. [PMID: 30113082 DOI: 10.1111/cei.13203] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
4 Vasiljević N, Marković L. [Gene similarity between hepatitis C virus and human proteins--a blood transfusion problem]. Med Pregl 2005;58:582-6. [PMID: 16673863 DOI: 10.2298/mpns0512582v] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Liberal R, Longhi MS, Mieli-vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Practice & Research Clinical Gastroenterology 2011;25:653-64. [DOI: 10.1016/j.bpg.2011.09.009] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 8.6] [Reference Citation Analysis]
6 Palazzi C, Buskila D, D’Angelo S, D’Amico E, Olivieri I. Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases. Autoimmun Rev. 2012;11:659-663. [PMID: 22155016 DOI: 10.1016/j.autrev.2011.11.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
7 Sousa GM, Oliveira RC, Pereira MM, Paraná R, Sousa-Atta ML, Atta AM. Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev. 2011;10:210-213. [PMID: 20951240 DOI: 10.1016/j.autrev.2010.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
8 Himoto T, Masaki T. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol. 2012;2012:871401. [PMID: 22988469 DOI: 10.1155/2012/871401].] [Reference Citation Analysis]
9 Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs AK, Vergani D. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol. 2004;39:981-987. [PMID: 15513338 DOI: 10.1080/00365520410003236] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
10 Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci. 2012;57:2248-2266. [PMID: 22562533 DOI: 10.1007/s10620-012-2179-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 7.2] [Reference Citation Analysis]
11 Daschakraborty S, Aggarwal A, Aggarwal R. Non-organ-specific autoantibodies in Indian patients with chronic liver disease. Indian J Gastroenterol. 2012;31:237-242. [PMID: 22941677 DOI: 10.1007/s12664-012-0247-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
12 Vierling JM. The Pathogenesis of Autoimmune Hepatitis. In: Hirschfield GM, Heathcote EJ, editors. Autoimmune Hepatitis. New York: Springer; 2012. pp. 3-49. [DOI: 10.1007/978-1-60761-569-9_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Koutsoumpas A, Polymeros D, Tsiamoulos Z, Smyk D, Karamanolis G, Triantafyllou K, Rigopoulou EI, Forbes A, Vergani D, Bogdanos DP. Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. J Crohns Colitis. 2011;5:101-109. [PMID: 21453878 DOI: 10.1016/j.crohns.2010.10.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang X, Xie QX, Zhao DM. Negative conversion of autoantibody profile in chronic hepatitis B: A case report. World J Clin Cases 2021;9:1196-203. [PMID: 33644184 DOI: 10.12998/wjcc.v9.i5.1196] [Reference Citation Analysis]
15 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006;12:1205-10. [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
16 Terziroli Beretta-piccoli B, Di Bartolomeo C, Deleonardi G, Grondona AG, Silvestri T, Tesei C, Melidona L, Cerny A, Mertens J, Semmo N, Semela D, Moradpour D, Mieli-vergani G, Vergani D, Muratori L. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. Journal of Autoimmunity 2019;102:89-95. [DOI: 10.1016/j.jaut.2019.04.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
17 Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol. 2014;20:613-629. [PMID: 24574735 DOI: 10.3748/wjg.v20.i3.613] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 65] [Article Influence: 12.3] [Reference Citation Analysis]
18 Gatselis NK, Georgiadou SP, Koukoulis GK, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C. Aliment Pharmacol Ther. 2006;24:1563-1573. [PMID: 17094775 DOI: 10.1111/j.1365-2036.2006.03165.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
19 Glišić S, Cavanaugh DP, Chittur KK, Sencanski M, Perovic V, Bojić T. Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3. BMC Bioinformatics 2016;17:139. [PMID: 27000565 DOI: 10.1186/s12859-016-0988-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
20 Czaja AJ. Autoimmune hepatitis. Part A: pathogenesis. Expert Rev Gastroenterol Hepatol. 2007;1:113-128. [PMID: 19072440 DOI: 10.1586/17474124.1.1.113] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
21 Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology. 2006;131:85-96. [PMID: 16831593 DOI: 10.1053/j.gastro.2006.04.021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
22 Lobo FP, Mota BE, Pena SD, Azevedo V, Macedo AM, Tauch A, Machado CR, Franco GR. Virus-host coevolution: common patterns of nucleotide motif usage in Flaviviridae and their hosts. PLoS One 2009;4:e6282. [PMID: 19617912 DOI: 10.1371/journal.pone.0006282] [Cited by in Crossref: 118] [Cited by in F6Publishing: 102] [Article Influence: 9.8] [Reference Citation Analysis]
23 Afsharzadeh F, Bokharaei-Salim F, Esghaei M, Monavari SH, Merat S, Poustchi H, Haj-Sheykholeslami A, Keyvani H. The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection. Hepat Mon 2016;16:e42388. [PMID: 28123444 DOI: 10.5812/hepatmon.42388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
24 Himoto T, Masaki T. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol 2012;2012:871401. [PMID: 22988469 DOI: 10.1155/2012/871401] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
25 Mavropoulos A, Orfanidou T, Liaskos C, Smyk DS, Billinis C, Blank M, Rigopoulou EI, Bogdanos DP. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmun Rev 2013;12:580-90. [PMID: 23207287 DOI: 10.1016/j.autrev.2012.10.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
26 Smyk D, Rigopoulou EI, Zen Y, Abeles RD, Billinis C, Pares A, Bogdanos DP. Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis? World J Gastroenterol 2012;18:4855-65. [PMID: 23002357 DOI: 10.3748/wjg.v18.i35.4855] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
27 Vergani D, Mieli-Vergani G. Cutting edge issues in autoimmune hepatitis. Clin Rev Allergy Immunol. 2012;42:309-321. [PMID: 21207191 DOI: 10.1007/s12016-010-8236-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
28 Hudacko RM, Alvarez GA, Talal AH, Jacobson I, Wan DW, Zhou XK, Yantiss RK. Clinical and biologic importance of F-actin autoantibodies in HCV monoinfected and HCV-HIV coinfected patients. Am J Clin Pathol. 2010;134:228-234. [PMID: 20660325 DOI: 10.1309/AJCPXSSF2ZZ8NYVZ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun. 2010;34:7-14. [PMID: 19766456 DOI: 10.1016/j.jaut.2009.08.010] [Cited by in Crossref: 122] [Cited by in F6Publishing: 113] [Article Influence: 10.2] [Reference Citation Analysis]
30 Vitozzi S, Lapierre P, Djilali-saiah I, Marceau G, Beland K, Alvarez F. Anti-Soluble Liver Antigen (SLA) Antibodies in Chronic HCV Infection. Autoimmunity 2009;37:217-22. [DOI: 10.1080/08916930410001686260] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
31 Ibáñez-samaniego L, Salcedo M, Vaquero J, Bañares R. De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1: ibáñez-Samaniego et al. Liver Transpl 2017;23:75-85. [DOI: 10.1002/lt.24652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Penalva Polo JC, Verdú Benavente C, Belda Abad G, Ruiz JA, Gaspar Martínez E, Correa Estañ JA, Muñoz Ramírez E, Martínez Prieto C. [Persistent acute hepatitis in a patient with chronic hepatitis C]. Gastroenterol Hepatol 2006;29:451-4. [PMID: 17020678 DOI: 10.1157/13092564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Milkiewicz M, Caballería L, Smyk DS, Milkiewicz P. Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies. Auto Immun Highlights 2012;3:105-12. [PMID: 26000133 DOI: 10.1007/s13317-012-0038-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Gilman AJ, Le AK, Zhao C, Hoang J, Yasukawa LA, Weber SC, Vierling JM, Nguyen MH. Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations. BMJ Open Gastroenterol 2018;5:e000203. [PMID: 29755758 DOI: 10.1136/bmjgast-2018-000203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
35 Trivedi PJ, Hirschfield GM. Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther. 2012;36:517-533. [PMID: 22817525 DOI: 10.1111/j.1365-2036.2012.05223.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
36 Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP. Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol. 2012;42:199-212. [PMID: 21337133 DOI: 10.1007/s12016-011-8259-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
37 Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, Babitt JL, Tangren JS, Hashemi N, Lundquist AL, Williams WW, Mount DB, Andersson KL, Rennke HG, Smith RN, Colvin R, Thadhani RI, Chung RT. Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy. Kidney Int Rep 2016;1:135-43. [PMID: 27990496 DOI: 10.1016/j.ekir.2016.06.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
38 Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study. World J Gastroenterol. 2005;11:482-487. [PMID: 15641130 DOI: 10.3748/wjg.v11.i4.482] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
39 Kusalik A, Bickis M, Lewis C, Li Y, Lucchese G, Marincola FM, Kanduc D. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides 2007;28:1260-7. [PMID: 17485143 DOI: 10.1016/j.peptides.2007.04.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
40 Czaja AJ. Autoantibodies in autoimmune liver disease. Adv Clin Chem. 2005;40:127-164. [PMID: 16355922 DOI: 10.1016/s0065-2423(05)40004-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
41 Calise SJ, Chan EKL. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery. Autoimmun Rev 2020;19:102643. [PMID: 32805424 DOI: 10.1016/j.autrev.2020.102643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
42 Brahimi K, Martins YC, Zanini GM, Ferreira-da-Cruz Mde F, Daniel-Ribeiro CT. Monoclonal auto-antibodies and sera of autoimmune patients react with Plasmodium falciparum and inhibit its in vitro growth. Mem Inst Oswaldo Cruz 2011;106 Suppl 1:44-51. [PMID: 21881756 DOI: 10.1590/s0074-02762011000900006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
43 Himoto T, Nishioka M. Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights. 2013;4:39-53. [PMID: 26000142 DOI: 10.1007/s13317-013-0046-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
44 Smyk DS, Rigopoulou EI, Lleo A, Abeles RD, Mavropoulos A, Billinis C, Invernizzi P, Bogdanos DP. Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing 2011;8:12. [PMID: 22136162 DOI: 10.1186/1742-4933-8-12] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
45 Andrade LJ, Melo PR, Atta AM, Atta ML, Jesus LS, Sousa GM, Silva CA, Paraná R. Smooth muscle antibodies and cryoglobulinemia are associated with advanced liver fibrosis in Brazilian hepatitis C virus carriers. Braz J Infect Dis 2011;15:66-8. [PMID: 21412592 DOI: 10.1016/s1413-8670(11)70142-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Gkoutzourelas A, Liaskos C, Mytilinaiou MG, Simopoulou T, Katsiari C, Tsirogianni A, Daoussis D, Scheper T, Meyer W, Bogdanos DP, Sakkas LI. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis. Front Immunol 2018;9:2835. [PMID: 30581434 DOI: 10.3389/fimmu.2018.02835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
47 Sousa GM, Oliveira IS, Andrade LJ, Sousa-Atta ML, Paraná R, Atta AM. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection. Cytokine. 2012;60:138-142. [PMID: 22748467 DOI: 10.1016/j.cyto.2012.06.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
48 Czaja AJ. The role of autoantibodies as diagnostic markers of autoimmune hepatitis. Expert Rev Clin Immunol. 2006;2:33-48. [PMID: 20477086 DOI: 10.1586/1744666x.2.1.33] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
49 Cheng M, Chan CW, Cheung RC, Bikkavilli RK, Zhao Q, Au SW, Chan PK, Lee SS, Cheng G, Ho WK, Cheung WT. Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11. Biochem Biophys Res Commun 2005;338:1654-60. [PMID: 16263078 DOI: 10.1016/j.bbrc.2005.10.088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
50 Bogdanos DP, Gao B, Gershwin ME. Liver immunology. Compr Physiol. 2013;3:567-598. [PMID: 23720323 DOI: 10.1002/cphy.c120011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
51 Böckle BC, Sepp NT. Hepatitis C virus and autoimmunity. Auto Immun Highlights 2010;1:23-35. [PMID: 26000104 DOI: 10.1007/s13317-010-0005-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
52 Tomasiewicz K, Pokora-Pachowicz A, Kiciak S. Autoimmune reactions in the course of the hepatitis C virus (HCV) infection. Clin Exp Hepatol 2015;1:39-43. [PMID: 28856254 DOI: 10.5114/ceh.2015.51804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Berger G. Escape of pathogens from the host immune response by mutations and mimicry. Possible means to improve vaccine performance. Med Hypotheses 2015;85:664-9. [PMID: 26341417 DOI: 10.1016/j.mehy.2015.08.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
54 Liberal R, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: From mechanisms to therapy. Rev Clin Esp. 2016;216:372-383. [PMID: 27161382 DOI: 10.1016/j.rce.2016.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
55 Probst C, Radzimski C, Blöcker IM, Teegen B, Bogdanos DP, Stöcker W, Komorowski L. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against “rings and rods”-associated inosine-5’-monophosphate dehydrogenase 2 in viral hepatitis C. Clin Chim Acta. 2013;418:91-96. [PMID: 23333419 DOI: 10.1016/j.cca.2013.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
56 Stinton LM, Myers RP, Coffin CS, Fritzler MJ. Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection. BMC Gastroenterol 2013;13:50. [PMID: 23506439 DOI: 10.1186/1471-230X-13-50] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
57 Vergani D, Mieli-Vergani G. Autoimmune manifestations in viral hepatitis. Semin Immunopathol. 2013;35:73-85. [PMID: 23010889 DOI: 10.1007/s00281-012-0328-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
58 Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009;36:30-39. [PMID: 18498061 DOI: 10.1007/s12016-008-8087-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
59 Bogdanos D, Mieli-vergani G, Vergani D. Non-Organ-Specific Autoantibodies in Hepatitis C Virus Infection: Do They Matter? Clinical Infectious Diseases 2005;40:508-10. [DOI: 10.1086/427293] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
60 Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139:58-72.e4. [PMID: 20451521 DOI: 10.1053/j.gastro.2010.04.053] [Cited by in Crossref: 184] [Cited by in F6Publishing: 157] [Article Influence: 16.7] [Reference Citation Analysis]
61 Gulli F, Basile U, Gragnani L, Fognani E, Napodano C, Colacicco L, Miele L, De Matthaeis N, Cattani P, Zignego AL, Rapaccini GL. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders. Digestive and Liver Disease 2016;48:927-33. [DOI: 10.1016/j.dld.2016.05.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
62 Gehring S, Kullmer U, Koeppelmann S, Gerner P, Wintermeyer P, Wirth S. Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha. World J Gastroenterol. 2006;12:5787-5792. [PMID: 17007043 DOI: 10.3748/wjg.v12.i36.5787] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
63 Bogdanos DP, Rigopoulou EI. Self-mimicking autoimmune domains of hepatitis C virus core antigen. Vaccine 2006;24:6173-4. [DOI: 10.1016/j.vaccine.2006.05.069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]